China to finally inoculate its senior citizens with single dose Covid-19 vaccine

By: |
March 30, 2021 6:51 PM

According to China's National Health Commission, (NHC) over 110 million people have been given COVID-19 vaccines in China so far but only for people between 18 to 59 years. People above 59 years are yet to be given the jabs, state-run Global Times reported.

China also says it has shipped 100 million vaccines abroad but yet to vaccinate its elderly.China also says it has shipped 100 million vaccines abroad but yet to vaccinate its elderly.

China has finally announced plans to inoculate COVID-19 vaccine to its senior citizens aged 60 and above but they would be provided only one jab without a booster as it is not recommended for now, a media report said on Tuesday.

According to China’s National Health Commission, (NHC) over 110 million people have been given COVID-19 vaccines in China so far but only for people between 18 to 59 years. People above 59 years are yet to be given the jabs, state-run Global Times reported.

China also says it has shipped 100 million vaccines abroad but yet to vaccinate its elderly.

China’s population of 60 years and above crossed 260 million, according to official data released recently. NHC in its first official COVID-19 vaccination guidelines on Monday, suggesting seniors aged 60 and above get inoculated as current clinical research data showed that vaccination is safe for senior citizens.

It also noted COVID-19 vaccine booster shots are not recommended for now, the report said. The guidelines also noted it is not recommended for people under the age of 18 to get vaccinated for now. The guidelines suggested seniors aged 60 and above should get vaccinated, saying that the data from Phase I and Phase II clinical studies of four conditionally approved vaccines showed that vaccination is safe for this group, even though there is no data on the protective efficacy of the vaccines yet, it said.

Compared with people aged 18-59, the neutralising antibody titer of senior citizens after vaccination is slightly lower, but the seroconversion rate of neutralising antibodies is similar, the guidelines said.

China has authorised five COVID-19 vaccines for conditional marketing or emergency use, including three inactivated vaccines, one adenovirus vector vaccine, and one recombinant protein sub-unit vaccine

Although booster shots are still not suggested, Zhang Yuntao, a vice president and chief scientist of China National Biotec Group, a Sinopharm subsidiary told media on Sunday that the group has designed COVID-19 booster shots to effectively improve the durability of antibodies, the report said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1No room for complacency in COVID-19 fight, absolute case numbers still high: MHA to states
2World Hepatitis Day 2021 – All you need to know about hepatitis and liver cancer
3Delhi records 67 COVID-19 cases, 3 fatalities in a day; positivity rate 0.09 pc